We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+11.07%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$48.8B
AUM Growth
+$7.31B
(+18%)
Cap. Flow
+$2.97B
Cap. Flow
% of AUM
6.1%
Top 10 Holdings %
Top 10 Hldgs %
18.45%
Holding
760
New
71
Increased
309
Reduced
252
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$305M |
| 2 |
CVS Health
CVS
|
+$190M |
| 3 |
Novartis
NVS
|
+$175M |
| 4 |
Broadcom
AVGO
|
+$154M |
| 5 |
Western Digital
WDC
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halliburton
HAL
|
+$260M |
| 2 |
UnitedHealth
UNH
|
+$217M |
| 3 |
United Parcel Service
UPS
|
+$140M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$137M |
| 5 |
McKesson
MCK
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.38% |
| 2 | Healthcare | 15.25% |
| 3 | Technology | 13.09% |
| 4 | Industrials | 10.62% |
| 5 | Energy | 10.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDCI
501
DELISTED
MEDICAL ACTION INDS INC
MDCI
| $5.24M | 0.01% |
611,815
+104,400
| +21% | +$753K |
|
502
FedEx
FDX
$74.5B
| $5.24M | 0.01% |
36,410
-14,445
| -28% | -$1.91M |
|
|
SPLK
503
PUT
DELISTED
Splunk Inc
SPLK
| $5.22M | 0.01% |
+76,000
| New | +$4.93M |
|
504
NorthWestern Energy
NWE
$4.48B
| $5.21M | 0.01% |
120,215
-42,140
| -26% | -$1.88M |
|
505
Apple
AAPL
$4.89T
| $5.14M | 0.01% |
256,592
+44,884
| +21% | +$848K |
|
|
PMC
506
DELISTED
PharMerica Corporation
PMC
| $5.13M | 0.01% |
238,661
-55,771
| -19% | -$1.01M |
|
507
Jabil
JBL
$32.8B
| $5.08M | 0.01% |
+291,337
| New | +$5.91M |
|
508
Aecom
ACM
$9.07B
| $5.07M | 0.01% |
172,156
+78,104
| +83% | +$2.36M |
|
|
CLD
509
DELISTED
Cloud Peak Energy Inc
CLD
| $5.06M | 0.01% |
+280,923
| New | +$4.57M |
|
510
Teva Pharmaceuticals
TEVA
$35.9B
| $5.04M | 0.01% |
125,692
| – | – |
|
|
VG
511
DELISTED
Vonage Holdings Corporation
VG
| $5.01M | 0.01% |
+1,503,419
| New | +$5.06M |
|
|
FMER
512
DELISTED
FIRSTMERIT CORP
FMER
| $5M | 0.01% |
225,162
-2,145
| -0.9% | -$48.2K |
|
|
BRSS
513
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $4.97M | 0.01% |
+300,121
| New | +$5.28M |
|
514
NOV
NOV
$7.45B
| $4.95M | 0.01% |
68,974
| – | – |
|
|
QVCGA
515
DELISTED
QVC Group Inc Series A
QVCGA
| $4.95M | 0.01% |
4,103
| – | – |
|
|
BIRT
516
DELISTED
Actuate Corp
BIRT
| $4.93M | 0.01% |
638,918
-262,069
| -29% | -$2.01M |
|
|
CCRN
517
DELISTED
Cross Country Healthcare
CCRN
| $4.92M | 0.01% |
493,230
-32,324
| -6% | -$224K |
|
|
PWRD
518
DELISTED
PERFECT WORLD CO LTD SPONSORED ADR REPSTG CL B (CAYMAN ISL)
PWRD
| $4.9M | 0.01% |
275,661
-131,079
| -32% | -$2.41M |
|
519
Morgan Stanley
MS
$337B
| $4.84M | 0.01% |
154,512
-46,731
| -23% | -$1.39M |
|
|
GOV
520
DELISTED
Government Properties Income Trust
GOV
| $4.83M | 0.01% |
194,145
+7,210
| +4% | +$177K |
|
521
Steven Madden
SHOO
$3.12B
| $4.82M | 0.01% |
197,729
-1,869
| -0.9% | -$45.5K |
|
522
MidCap Financial Investment
MFIC
$784M
| $4.78M | 0.01% |
187,719
-2,493
| -1% | -$64.1K |
|
|
BBRG
523
DELISTED
Bravo Brio Restaurant Group Inc.
BBRG
| $4.74M | 0.01% |
291,095
+46,960
| +19% | +$730K |
|
|
FFIC
524
DELISTED
Flushing Financial
FFIC
| $4.58M | 0.01% |
221,407
-910
| -0.4% | -$18.3K |
|
|
BGC
525
DELISTED
General Cable Corporation
BGC
| $4.58M | 0.01% |
155,580
| – | – |
|
Similar funds
Boston Partners's Q4 2013 Portfolio in Review
As of Q4 2013, Boston Partners held 760 positions worth $48.8B, up 18% from $41.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Boston Partners deployed $2.97B of net new capital in Q4 2013, opening 71 new positions and adding to 309 existing holdings. Its largest new stake was Novartis: 2,524,138 shares worth $182M.
By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Halliburton, an estimated $260M trimmed.
- Boston Partners's largest Q4 2013 buy was Novartis: 2,524,138 shares worth $182M.
- Boston Partners added most to ExxonMobil in Q4 2013, an estimated $305M increase.
- Boston Partners's biggest Q4 2013 reduction was Halliburton, cutting an estimated $260M.
- Boston Partners fully exited NVIDIA in Q4 2013, selling an estimated $131M.
- Boston Partners's ten largest holdings make up 18% of its $48.8B portfolio in Q4 2013.
- Boston Partners opened 71 new positions and closed 53 in Q4 2013.
- Boston Partners's portfolio value rose 18% quarter-over-quarter to $48.8B.
Based on Boston Partners's 13F filing for Q4 2013, filed 6 Feb 2014.